Atlas Trials

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Clinical trial NCT02723331 · COMPLETED

Trial details

NCT number
NCT02723331
Sponsor
Academic Thoracic Oncology Medical Investigators Consortium
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma
Start date
2016-12-30
Primary completion
2022-12-08
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.